You are about to be taken to a third-party site. The content on this site is for informational use only. L-Nutra does not endorse any of the information, products, or services on third-party sites, and no information on third-party sites should be construed as an endorsement or recommendation of specific L-Nutra products. By clicking on the link below, you consent to be directed to external material.Proceed Cancel
Beyond individual health benefits, Fasting Mimicking Technology is a true breakthrough with the potential to change both everyday health maintenance as well as the course of health care. In fact, recent studies have uncovered potential effects of this technology platform on numerous chronic health conditions such as diabetes, cancer, Alzheimer’s, and various cardiovascular and autoimmune diseases. L-Nutra, through its drug development arm, is currently developing and testing specific formulations based on the Fasting Mimicking Technology platform for patients with each of these conditions.
Fasting Mimicking Technology was developed at the Longevity Institute of the University of Southern
California by a team of researchers led by Professor Valter Longo. After over a decade of research into the powerful health benefits of water fasting in mice, the researchers attempted to test water fasting in humans but quickly ran into compliance and safety issues that threatened their progress. However, the National Institutes of Health (NIH) recognized the importance of the project and granted millions of dollars to the team with the specific goal of developing Fasting Mimicking Technology (and thereby eliminating the need to test water-only fasting). The rest is history.
Today, based on promising results from our preclinical studies and early human trials, 16 top universities across the globe are testing a Fasting Mimicking Technology formulation for applications in longevity and disease prevention. Many institutions have also continued to work with L-Nutra in researching other Fasting Mimicking Technology formulations as therapies for the top five most lethal diseases known to mankind – diabetes, cancer, Alzheimer’s, and cardiovascular and autoimmune diseases. These institutions have helped tremendously in furthering our understanding of fasting and Fasting Mimicking Technology. Their inclusion here does not imply product endorsement, but is our way of recognizing some them for their contributions to our scientific progress.